CEOR_A_295494 191..200
暂无分享,去创建一个
D. Ost | Y. Chiu | R. Culbertson | M. Simoff | Dean G. Smith | Y. Kao | O. Wagner | J. Lavin
[1] Lizheng Shi,et al. Biopsy frequency and complications among lung cancer patients in the United States , 2020, Lung cancer management.
[2] J. Huo,et al. Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting , 2019, JAMA internal medicine.
[3] E. Ziv,et al. Autologous Blood Patch Injection versus Hydrogel Plug in CT-guided Lung Biopsy: A Prospective Randomized Trial. , 2019, Radiology.
[4] S. Kothari,et al. Biopsy Procedures and Molecular Testing Utilization and Related Costs in Patients with Metastatic Lung Cancer , 2016, Journal of managed care & specialty pharmacy.
[5] M. Oudkerk,et al. Complication rates of CT-guided transthoracic lung biopsy: meta-analysis , 2016, European Radiology.
[6] Edward S. Kim,et al. Lung cancer biomarkers, targeted therapies and clinical assays. , 2015, Translational lung cancer research.
[7] Yi-Lin Wu,et al. Estimating the lifelong health impact and financial burdens of different types of lung cancer , 2013, BMC Cancer.
[8] D. Naidich,et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.
[9] Paul J Nietert,et al. Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. , 2012, Chest.
[10] Lisa M. Schwartz,et al. Population-based risk of complications following transthoracic needle lung biopsy of a pulmonary nodule , 2011 .
[11] Eric J Feuer,et al. Projections of the cost of cancer care in the United States: 2010-2020. , 2011, Journal of the National Cancer Institute.
[12] F. Bartolomucci,et al. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. , 2009, The Annals of thoracic surgery.
[13] S. Ramsey,et al. Sensitivity of Administrative Claims to Identify Incident Cases of Lung Cancer: A Comparison of 3 Health Plans , 2009, Journal of managed care pharmacy : JMCP.
[14] H. Quan,et al. Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data , 2005, Medical care.
[15] Rosa M. Estrada-Y.-Martin,et al. Diagnostic Yield and Complications of Bronchoscopy for Peripheral Lung Lesions. Results of the AQuIRE Registry. , 2016, American journal of respiratory and critical care medicine.
[16] Hodgkin Lymphoma. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines , 2014 .
[17] Krishna S. Vyas,et al. Mediastinoscopy: trends and practice patterns in the United States. , 2013, Southern medical journal.
[18] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.